Results 1 to 10 of about 298,365 (156)

Melanoma [PDF]

open access: yesJournal of the National Comprehensive Cancer Network, 2012
Melanoma is a relatively common neoplasm which is increasing in incidence. Melanoma appears as a variegated irregular maculopapular lesion usually on the skin, but possibly on mucosae, conjunctiva, orbit, nails and oesophagus. They may be black, brown,
Magri, Stephanie, Pace, Keith
core   +4 more sources

The effect of COVID-19 emergency in the management of melanoma in Italy

open access: yesDermatology Reports, 2021
The COVID-19 pandemic has severely hampered the functioning of any health system, absorbing a considerable amount of resources and with the threat of widespread infection in the health services.
Intergruppo Melanoma Italiano
doaj   +1 more source

XXVI IMI National Congress - 1st virtual edition | 7-9 November 2020

open access: yesDermatology Reports, 2021
s from the XXVI IMI National Congress (virtual edition).
Italian Melanoma Intergroup (IMI)
doaj   +1 more source

Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approach

open access: yesJournal of Translational Medicine, 2023
Background Gene expression profiling is increasingly being utilised as a diagnostic, prognostic and predictive tool for managing cancer patients. Single-sample scoring approach has been developed to alleviate instability of signature scores due to ...
Yizhe Mao   +17 more
doaj   +1 more source

Lag-3 expression and clinical outcomes in metastatic melanoma patients treated with combination anti-lag-3 + anti-PD-1-based immunotherapies

open access: yesOncoImmunology, 2023
Lymphocyte-activation gene-3 (LAG-3), an immune checkpoint receptor, negatively regulates T-cell function and facilitates immune escape of tumors. Dual inhibition of LAG-3 and programmed cell death receptor-1 (PD-1) significantly improved progression ...
Tuba N. Gide   +9 more
doaj   +1 more source

XXVIII Italian Melanoma Intergroup National Congress - Florence, Italy | 30 September-2 October 2022

open access: yesDermatology Reports, 2023
s from the Italian Melanoma Intergroup (IMI) National ...
Italian Melanoma Intergroup (IMI)
doaj   +1 more source

Melanoma

open access: yesAtención Primaria, 2004
The incidence of malignant melanoma in the UK is still rising despite public health warnings about the risks of excessive sun exposure. This aggressive tumour can metastasize to virtually any organ, even years after resection of the primary lesion and cause a variety of radiological appearances.
Casanova Seuma, J.M.   +1 more
openaire   +4 more sources

Lysine Demethylases: Promising Drug Targets in Melanoma and Other Cancers

open access: yesFrontiers in Genetics, 2021
Epigenetic dysregulation has been implicated in a variety of pathological processes including carcinogenesis. A major group of enzymes that influence epigenetic modifications are lysine demethylases (KDMs) also known as “erasers” which remove methyl ...
Gaya Punnia-Moorthy   +9 more
doaj   +1 more source

Demographic, Clinical, and Pathologic Features of Patients With Cutaneous Melanoma: Final Analysis of the Brazilian Melanoma Group Database

open access: yesJCO Global Oncology, 2020
PURPOSE National epidemiologic data on melanoma are scarce in Brazil. The current work presents final demographic, clinical, and pathologic results from the Brazilian Melanoma Group database to detail how patients with melanoma present at diagnosis ...
Alberto Julius Alves Wainstein   +20 more
doaj   +1 more source

Melanoma [PDF]

open access: yesCanadian Medical Association Journal, 2019
AbstractCurrent recommendations by the United States Preventive Services Task Force do not support screening for skin cancer. Melanoma is unique among cancers because detection is through visual inspection. Development of technologies that aid visual inspection have supported screening strategies in high‐risk populations such as older fair skinned ...
Robert, Micieli, Kucy, Pon
openaire   +4 more sources

Home - About - Disclaimer - Privacy